MENU
DYN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Dyne Therapeutics (DYN) Earnings Date & Reports

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases... Show more

A.I. Advisor
published Earnings

DYN is expected to report earnings to fall 11.49% to -85 cents per share on October 30

Dyne Therapeutics DYN Stock Earnings Reports
Q3'25
Est.
$-0.86
Q2'25
Missed
by $0.03
Q1'25
Missed
by $0.20
Q4'24
Beat
by $0.06
Q3'24
Missed
by $0.25
The last earnings report on July 28 showed earnings per share of -97 cents, missing the estimate of -93 cents. With 748.65K shares outstanding, the current market capitalization sits at 1.59B.
View a ticker or compare two or three
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. DYN showed earnings on July 28, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Electric Utilities
Address
1560 Trapelo Road
Phone
+1 781 786-8230
Employees
141
Web
https://www.dyne-tx.com